CCAR2 and hepatocellular carcinoma: A recent study investigated the clinical value of DBC1/KIAA1967 in hepatocellular carcinoma, analyzing its prognostic ability with survival analysis; a higher expression of DBC1/KIAA1967 reduced overall survival and disease free survival [30].